OPT

Opthea Limited

3.20 USD
+0.68 (+26.98%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Opthea Limited stock is down -10.61% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 12 June’s closed higher than May.

About Opthea Limited

Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME.